Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study

被引:11
作者
Chidambaram, Swathikan [1 ]
Owen, Richard [2 ,3 ]
Sgromo, Bruno [2 ]
Chmura, Magdalena [2 ]
Kisiel, Aaron [4 ]
Evans, Richard [4 ]
Griffiths, Ewen A. [4 ]
Castoro, Carlo [5 ]
Gronnier, Caroline [6 ]
Maoawyes, Mometo Ali [7 ]
Gutschow, Christian A. [7 ]
Piessen, Guillaume [8 ]
Degisors, Sebastien [8 ]
Alvieri, Rita [9 ]
Feldman, Hope [10 ]
Capovilla, Giovanni [11 ]
Grimminger, Peter P. [11 ]
Han, Shiwei [12 ,13 ]
Low, Donald E. [12 ,13 ]
Moore, Jonathan [14 ]
Gossage, James [14 ]
Voeten, Dan [15 ]
Gisbertz, Suzanne S. [15 ]
Ruurda, Jelle [16 ]
van Hillegersberg, Richard [16 ]
D'Journo, Xavier B. [17 ]
Chmelo, Jakub [18 ]
Phillips, Alexander W. [18 ]
Rosati, Riccardo [19 ]
Hanna, George B. [1 ]
Maynard, Nick [2 ]
Hofstetter, Wayne [10 ]
Ferri, Lorenzo [20 ]
Berge Henegouwen, Mark I. [15 ]
Markar, Sheraz R. [2 ,21 ]
机构
[1] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Acad Surg Unit, London, England
[2] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Surg, Oxford, England
[3] Univ Oxford, Ludwig Inst Canc Res, Oxford, England
[4] Birmingham Univ Hosp NHS Fdn Trust, Queen Elizabeth Hosp, Dept Surg, Birmingham, England
[5] Humanitas Res Hosp, Gen Gastr & Esophagus Surg Unit, Rozzano, Italy
[6] CHU Bordeaux, Ctr Magellan, Digest Surg Dept, Esophageal & Endocrine Surg Unit, Bordeaux, France
[7] Univ Hosp Zurich, Comprehens Canc Ctr, Stomach & Oesophageal Tumor Ctr, Zurich, Switzerland
[8] Univ Hosp Claude Huriez, Dept Digest & Gen Surg, Cedex, Lille, France
[9] IOV IRCCS, Veneto Inst Oncol, Oncol Surg Unit, Padua, Italy
[10] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[11] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Surg, Mainz, Germany
[12] Virginia Mason Hosp, Dept Thorac Surg & Thorac Oncol, Seattle, WA USA
[13] Seattle Med Ctr, Seattle, WA USA
[14] Guys & St Thomas Hosp NHS Fdn Trust, Dept Surg, London, England
[15] Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands
[16] Univ Med Ctr, Dept Upper Gastrointestinal Surg, Utrecht, Netherlands
[17] North Hosp, Dept Thorac Surg Dis Esophagus & Lung Transplantat, Chemin Bourrely, Marseille, France
[18] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Northern Esophagogastr Unit, Newcastle Upon Tyne, England
[19] Osped San Raffaele, Dept GI Surg, Milan, Italy
[20] McGill Univ, Montreal Gen Hosp, Dept Surg & Oncol, Montreal, PQ, Canada
[21] Univ Oxford, Nuffield Dept Surg, Oxford, England
关键词
chemoradiotherapy; esophageal cancer; esophagectomy; salvage esophagectomy; PHASE-III TRIAL; RADIATION-THERAPY; SURGERY; CHEMORADIATION; RADIOTHERAPY; MORBIDITY; MORTALITY; SURVIVAL; OUTCOMES;
D O I
10.1097/SLA.0000000000006028
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine the impact of delayed surgical intervention following chemoradiotherapy (CRT) on survival from esophageal cancer.Background: CRT is a core component of multimodality treatment for locally advanced esophageal cancer. The timing of surgery following CRT may influence the probability of performing an oncological resection and the associated operative morbidity.Methods: This was an international, multicenter, cohort study, including patients from 17 centers who received CRT followed by surgery between 2010 and 2020. In the main analysis, patients were divided into 4 groups based upon the interval between CRT and surgery (0-50, 51-100, 101-200, and >200 days) to assess the impact upon 90-day mortality and 5-year overall survival. Multivariable logistic and Cox regression provided hazard ratios (HRs) with 95% CIs adjusted for relevant patient, oncological, and pathologic confounding factors.Results: A total of 2867 patients who underwent esophagectomy after CRT were included. After adjustment for relevant confounders, prolonged interval following CRT was associated with an increased 90-day mortality compared with 0 to 50 days (reference): 51 to 100 days (HR=1.54, 95% CI: 1.04-2.29), 101 to 200 days (HR=2.14, 95% CI: 1.37-3.35), and >200 days (HR=3.06, 95% CI: 1.64-5.69). Similarly, a poorer 5-year overall survival was also observed with prolonged interval following CRT compared with 0 to 50 days (reference): 101 to 200 days (HR=1.41, 95% CI: 1.17-1.70), and >200 days (HR=1.64, 95% CI: 1.24-2.17).Conclusions: Prolonged interval following CRT before esophagectomy is associated with increased 90-day mortality and poorer long-term survival. Further investigation is needed to understand the mechanism that underpins these adverse outcomes observed with a prolonged interval to surgery.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 36 条
[1]  
Ajani JA., 2022, J Natl Compr Cancer Netw, V17, P855
[2]   Oesophageal preservation in locally advanced oesophageal cancer [J].
Ajani, Jaffer A. ;
Bhutani, Manoop S. ;
Swisher, Stephen G. .
LANCET ONCOLOGY, 2018, 19 (09) :E430-E430
[3]   Global burden of oesophageal and gastric cancer by histology and subsite in 2018 [J].
Arnold, Melina ;
Ferlay, Jacques ;
Henegouwen, Mark I. van Berge ;
Soerjomataram, Isabelle .
GUT, 2020, 69 (09) :1564-1571
[4]  
Baja SS., 2022, J Am Coll Surg, V235, P1075
[5]  
Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118
[6]   Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology [J].
Bentzen, Soren M. .
NATURE REVIEWS CANCER, 2006, 6 (09) :702-713
[7]   Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial [J].
Burmeister, BH ;
Smithers, BM ;
Gebski, V ;
Fitzgerald, L ;
Simes, RJ ;
Devitt, P ;
Ackland, S ;
Gotley, DC ;
Joseph, D ;
Millar, J ;
North, J ;
Walpole, ET ;
Denham, JW .
LANCET ONCOLOGY, 2005, 6 (09) :659-668
[8]  
Chidambaram S., 2023, Dis Esophagus, V36, pdoac058
[9]   Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01) [J].
Cooper, JS ;
Guo, MD ;
Herskovic, A ;
Macdonald, JS ;
Martenson, JA ;
Al-Sarraf, M ;
Byhardt, R ;
Russell, AH ;
Beitler, JJ ;
Spencer, S ;
Asbell, SO ;
Graham, MV ;
Leichman, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1623-1627
[10]  
Crehange G., 2016, J Clin Oncol, V34, P329